5th June 2026, Friday

TechPharus

Latest Posts

HealthTech News

  • Peach fuzz may hold clues to new chronic itch treatments
    on June 5, 2026 at 4:20 pm

    Working with mouse models, research led by the University of Michigan has revealed previously hidden biology of how touch-sensitive hairs create itching sensations. This fundamental discovery opens new avenues to better understand and potentially address human health conditions characterized by persistent itchiness.

  • Low-dose aspirin may offset premature birth risk linked to extreme heat
    on June 5, 2026 at 4:00 pm

    Mounting evidence links extreme heat to preterm (often called premature) birth, low birth weight, and stillbirth, indicating that rising temperatures are contributing to worse health outcomes for pregnant people and newborns. Preterm birth is already a leading cause of infant illness and death worldwide, with an estimated 12 to 15 million babies born too early each year, meaning even modest increases in heat-related risk could have substantial global consequences.

  • Light-triggered arrhythmia reveals rapid brain oxygen shifts in mice
    on June 5, 2026 at 3:40 pm

    An irregular heartbeat, or arrhythmia, leads to inefficient pumping of blood by the heart, which then prevents blood and oxygen from getting to the body’s other organs. When blood and oxygen flow poorly to the brain, the risk of stroke and cognitive decline increases.

  • Q&A: Expert discusses risks of cannabis use
    on June 5, 2026 at 3:40 pm

    On April 26, the United States reclassified cannabis from a Schedule I controlled substance, which lacks any medical benefits, to a Schedule III controlled substance, which has accepted medical uses and lower potential for misuse than a Schedule I substance.

  • Early immunotherapy aids in treating potentially fatal fungal pneumonias in preclinical models
    on June 5, 2026 at 3:20 pm

    A new study led by researchers at The University of Texas MD Anderson Cancer Center has shown that early administration of immunotherapy with standard antifungal treatment improved outcomes and largely alleviated immune system paralysis caused by fungal lung infections in preclinical models. These findings could herald new clinically relevant strategies for treating a variety of life-threatening invasive fungal pneumonias, which disproportionately affect immunocompromised cancer patients.